Catalyst Wire Dossier Catalyst Wire Dossier

Regranex (becaplermin) gel

becaplermin · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Regranex (becaplermin) gel, covering 2011-06-08 to 2011-06-08. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety Follow-up of Becaplermin or Placebo Gel Following Treatment of Chronic, Full Thickness Diabetic Ulcers

See pricing